Becton Dickinson and Co (BDX)

201.38
0.01 0.00
NYSE : Health Care
Prev Close 201.39
Open 201.13
Day Low/High 200.72 / 202.27
52 Wk Low/High 161.29 / 206.63
Volume 51.80K
Avg Volume 1.34M
Exchange NYSE
Shares Outstanding 227.56M
Market Cap 45.85B
EPS 4.60
P/E Ratio 58.57
Div & Yield 2.92 (1.40%)

Latest News

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

Jim Cramer says history doesn't have to repeat itself. You don't want to miss another opportunity in the highly visible FANG-style stocks.

Becton, Dickinson Achieves #93 Analyst Rank, Surpassing Parker Hannifin

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Becton, Dickinson & Co has taken over the #93 spot from Parker Hannifin Corp , according to ETF Channel. Below is a chart of Becton, Dickinson & Co versus Parker Hannifin Corp plotting their respective rank within the S&P 500 over time (BDX plotted in blue; PH plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

What Happened to American Society Is Happening to the Stock Market, Too: Market Recon

What Happened to American Society Is Happening to the Stock Market, Too: Market Recon

The S&P 500 has returned 10% year to date, while the top half of it, around 16%.

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Jim Cramer calls Baxter International, Becton Dickinson, and Boston Scientific the 'Killer Bs'.

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

Jim Cramer says he wishes Washington would just focus on repatriation and get a win for the U.S. economy and markets.

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.

BD Board Declares Dividend

BD Board Declares Dividend

FlowJo And BD To Provide Cloud Platform For Real-Time Single-Cell Marketing Collaboration

FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data, and global medical technology company, BD (Becton, Dickinson and Company) (NYSE:BDX),...

Short Interest Jumps 11.4% For BDX

The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 1,187,170 share increase in total short interest for Becton, Dickinson & Co , to 11,603,221, an increase of 11.40% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Kaon Interactive Wins Three Awards At DxMA Global Marketing Summit

Recognized for 3D interactive customer engagement applications developed for GE Healthcare and Becton Dickinson Diagnostics

BD Board Declares Dividend

Walgreens Boots Alliance, Becton Dickinson, General Mills: 'Mad Money' Lightning Round

Walgreens Boots Alliance, Becton Dickinson, General Mills: 'Mad Money' Lightning Round

Jim Cramer is bullish on Walgreens Boots Alliance, Becton Dickinson, and General Mills.

Going for the Growth: Cramer's 'Mad Money' Recap (Thursday 5/18/17)

Going for the Growth: Cramer's 'Mad Money' Recap (Thursday 5/18/17)

Money managers are piling back into growth stocks without hesitation, says Jim Cramer.

Market Recon: The Fear Gauge Is So Tiny, It's Adorable

Market Recon: The Fear Gauge Is So Tiny, It's Adorable

But investors should not take that as a sign it's a good idea to hedge by buying the VIX.

Week Ahead: Apple Earnings, Jobs Report on the Docket in Busy Start to May

Week Ahead: Apple Earnings, Jobs Report on the Docket in Busy Start to May

May kicks off with a busy first week filled with earnings, monetary policy and a snapshot of the health of the economy.

Merger Buzz Drives Akorn to Top of Health Chart in April

Merger Buzz Drives Akorn to Top of Health Chart in April

Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.

Good Medicine Makes for 3 Good Charts

Good Medicine Makes for 3 Good Charts

Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.

French Election Fires Up Wall Street, Propels Stocks to Best Gains Since Early March

French Election Fires Up Wall Street, Propels Stocks to Best Gains Since Early March

A vote for the status quo lights a fire under European markets, which translates to a great day for Wall Street.

Cramer: Sorry, Popeye, but Market Rally Isn't Just About the French Connection

Cramer: Sorry, Popeye, but Market Rally Isn't Just About the French Connection

Let's play out what's allowing our markets to fly: Earnings.